Session Information
2007 BIO International Convention
Click here to go to the previous page
Do's and Don'ts of Biotech Start-ups
Track : Emerging Company Issues
Program Code: ECI010
Date: Sunday, May 6, 2007
Time: 2:00 PM to 3:30 PM  
Location: 210 A
CHAIR :
J. Peter Fasse, PhD, Esq, Principal, Fish & Richardson P.C.
SPEAKER (S):
Stephen Bloch
Douglas Fambrough, PhD, Principal, Oxford Bioscience Partners
Elizabeth Douville, PhD, Vice President, GeneChem Management Inc.
Harry Penner Jr., Chairman & CEO, Marinus Pharmaceuticals, Inc.
Description
The panel will discuss the financial, legal and practical aspects of starting a company in the biotech and biomedical device arena. Good and bad practices will be discussed, including obtaining and arranging financing, corporate and intellectual property law strategies, personnel issues, partnering with other companies large and small, and simple steps and missteps that can help make or break a new company.



Objectives:
  • Discuss the real-life experiences of CEOs, investors and board members in growing an early-stage company.

  • Find out what criteria biotech investors use to evaluate and fund investment-grade projects.

  • Learn how to avoid big mistakes when forming a start-up.


  • Streaming Audio with
    PowerPoint Slides
    (Code: ECI010)
      
    This session is a part of: